Llwytho...
Alzheimer’s Disease in Down Syndrome: Progress in the Design and Conduct of Drug Prevention Trials
Individuals with Down syndrome (DS) are at high risk for developing Alzheimer’s disease (AD) pathology and this has provided significant insights into our understanding of the genetic basis of AD. The present review summarizes recent clinical, neuropathologic, imaging, and fluid biomarker studies of...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | CNS Drugs |
|---|---|
| Prif Awdur: | |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7395870/ https://ncbi.nlm.nih.gov/pubmed/32506291 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s40263-020-00740-6 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|